◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksI › IMCD

IMCD N.V. (IMCD) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Basic Materials · Specialty Chemicals · DATA UPDATED 2026-08-16

IMCD N.V. (IMCD) operates in the Specialty Chemicals industry and is headquartered in Rotterdam, Netherlands with about 5,237 employees. Its market capitalization is roughly €6 billion. In the fiscal year ended 2025-12-31, IMCD reported €4.8B in revenue and €218M in net income.

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific.

Interactive charts & full statements →

IMCD Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue€4.8B€4.7B€4.4B€4.6B
Gross Profit€1.2B€1.2B€1.1B€1.1B
Operating Income (EBIT)€371M€425M€428M€462M
Net Income€218M€278M€292M€313M

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMCD Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(€127M)(€128M)(€135M)(€92M)

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IMCD Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total Assets€4.6B€4.9B€4.2B€3.6B
Total Liabilities€2.6B€2.7B€2.4B€2.0B

EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IMCD viewer.

Other Companies in Specialty Chemicals

← IMCCAll “I” companiesIMCG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.